{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:26:57Z","timestamp":1787952417003,"version":"build-2784847793"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,8]]},"DOI":"10.7759\/cureus.16989","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T08:16:57Z","timestamp":1628410617000},"source":"Crossref","is-referenced-by-count":4,"title":["Sutureless Amniotic Membrane (ProKera\u00ae) and Intravenous Immunoglobulin in the Management of Ocular Complications of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis Overlap"],"prefix":"10.7759","author":[{"given":"Abdulhameed H","family":"Mahmood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah S","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader A","family":"Almanea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoud F","family":"Alsaati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.01.046","article-title":"Treatment of acute Stevens-Johnson syndrome and toxic epidermal necrolysis using amniotic membrane: a review of 10 consecutive cases","volume":"118","author":"Gregory DG","year":"2011","unstructured":"Gregory DG. Treatment of acute Stevens-Johnson syndrome and toxic epidermal necrolysis using amniotic membrane: a review of 10 consecutive cases. Ophthalmology. 2011, 118:908-14. 10.1016\/j.ophtha.2011.01.046","journal-title":"Ophthalmology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.10.027","article-title":"Adjuvant role of amniotic membrane transplantation in acute ocular Stevens-Johnson syndrome a randomized control trial","volume":"123","author":"Sharma N","year":"2016","unstructured":"Sharma N, Thenarasun SA, Kaur M, Pushker N, Khanna N, Agarwal T, Vajpayee RB. Adjuvant role of amniotic membrane transplantation in acute ocular Stevens-Johnson syndrome a randomized control trial. Ophthalmology. 2016, 123:484-91. 10.1016\/j.ophtha.2015.10.027","journal-title":"Ophthalmology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0b013e318255124f","article-title":"Placement of ProKera in the management of ocular manifestations of acute Stevens-Johnson syndrome in an outpatient","volume":"39","author":"Kolomeyer AM","year":"2013","unstructured":"Kolomeyer AM, Do BK, Tu Y, Chu DS. Placement of ProKera in the management of ocular manifestations of acute Stevens-Johnson syndrome in an outpatient. Eye Contact Lens. 2013, 39:e7-11. 10.1097\/ICL.0b013e318255124f","journal-title":"Eye Contact Lens"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7599\/hmr.2016.36.3.174","article-title":"Ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"36","author":"Kang MH","year":"2016","unstructured":"Kang MH. Ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis. Hanyang Med Rev. 2016, 36:174. 10.7599\/hmr.2016.36.3.174","journal-title":"Hanyang Med Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16685","article-title":"Systemic therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a SCORTEN-based systematic review and meta-analysis","volume":"35","author":"Torres-Navarro I","year":"2021","unstructured":"Torres-Navarro I, Briz-Red\u00f3n \u00c1, Botella-Estrada R. Systemic therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a SCORTEN-based systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2021, 35:159-71. 10.1111\/jdv.16685","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-0124(12)70059-9","article-title":"How does amniotic membrane work?","volume":"2","author":"Tseng S","year":"2004","unstructured":"Tseng S, Espana E, Kawakita T, et al.. How does amniotic membrane work?. Ocul Surf. 2004, 2:177-87. 10.1016\/S1542-0124(12)70059-9","journal-title":"Ocul Surf"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S45054","article-title":"Prompt versus delayed amniotic membrane application in a patient with acute Stevens-Johnson syndrome","volume":"7","author":"Ciralsky JB","year":"2013","unstructured":"Ciralsky JB, Sippel KC. Prompt versus delayed amniotic membrane application in a patient with acute Stevens-Johnson syndrome. Clin Ophthalmol. 2013, 7:1031-4. 10.2147\/OPTH.S45054","journal-title":"Clin Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.11.035","article-title":"Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome","volume":"112","author":"Di Pascuale MA","year":"2005","unstructured":"Di Pascuale MA, Espana EM, Liu DT, et al.. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology. 2005, 112:904-12. 10.1016\/j.ophtha.2004.11.035","journal-title":"Ophthalmology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2005.09.001","article-title":"Amniotic membrane transplantation in acute phase of toxic epidermal necrolysis with severe corneal involvement","volume":"113","author":"Kobayashi A","year":"2006","unstructured":"Kobayashi A, Yoshita T, Sugiyama K, Miyashita K, Niida Y, Koizumi S, Tseng SC. Amniotic membrane transplantation in acute phase of toxic epidermal necrolysis with severe corneal involvement. Ophthalmology. 2006, 113:126-32. 10.1016\/j.ophtha.2005.09.001","journal-title":"Ophthalmology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.131102","article-title":"Technique of amniotic membrane transplant dressing in the management of acute Stevens-Johnson syndrome","volume":"91","author":"Muqit MM","year":"2007","unstructured":"Muqit MM, Ellingham RB, Daniel C. Technique of amniotic membrane transplant dressing in the management of acute Stevens-Johnson syndrome. Br J Ophthalmol. 2007, 91:1536. 10.1136\/bjo.2007.131102","journal-title":"Br J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2007.04.020","article-title":"Amniotic membrane grafting for conjunctival and lid surface disease in the acute phase of toxic epidermal necrolysis","volume":"11","author":"Tandon A","year":"2007","unstructured":"Tandon A, Cackett P, Mulvihill A, Fleck B. Amniotic membrane grafting for conjunctival and lid surface disease in the acute phase of toxic epidermal necrolysis. J AAPOS. 2007, 11:612-3. 10.1016\/j.jaapos.2007.04.020","journal-title":"J AAPOS"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4274\/tjo.galenos.2019.13333","article-title":"Sutureless amniotic membrane transplantation in a pediatric patient with acute toxic epidermal necrolysis","volume":"49","author":"Ba\u015f Z","year":"2019","unstructured":"Ba\u015f Z, U\u00e7akhan G\u00fcnd\u00fcz \u00d6. Sutureless amniotic membrane transplantation in a pediatric patient with acute toxic epidermal necrolysis. Turk J Ophthalmol. 2019, 49:356-60. 10.4274\/tjo.galenos.2019.13333","journal-title":"Turk J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2015.07.002","article-title":"A novel technique for amniotic membrane transplantation in patients with acute Stevens-Johnson syndrome","volume":"14","author":"Ma KN","year":"2016","unstructured":"Ma KN, Thanos A, Chodosh J, Shah AS, Mantagos IS. A novel technique for amniotic membrane transplantation in patients with acute Stevens-Johnson syndrome. Ocul Surf. 2016, 14:31-6. 10.1016\/j.jtos.2015.07.002","journal-title":"Ocul Surf"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2017.06.018","article-title":"Sutureless amniotic membrane transplantation with a modified ocular surface ring","volume":"53","author":"Kara N","year":"2018","unstructured":"Kara N. Sutureless amniotic membrane transplantation with a modified ocular surface ring. Can J Ophthalmol. 2018, 53:e46-8. 10.1016\/j.jcjo.2017.06.018","journal-title":"Can J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2019.03.001","article-title":"Sutureless amniotic membrane transplantation with cyanoacrylate glue for acute Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"17","author":"Shanbhag SS","year":"2019","unstructured":"Shanbhag SS, Chodosh J, Saeed HN. Sutureless amniotic membrane transplantation with cyanoacrylate glue for acute Stevens-Johnson syndrome\/toxic epidermal necrolysis. Ocul Surf. 2019, 17:560-4. 10.1016\/j.jtos.2019.03.001","journal-title":"Ocul Surf"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0b013e3181a66a12","article-title":"Evaluation of the role of ProKera in the management of ocular surface and orbital disorders","volume":"35","author":"Pachigolla G","year":"2009","unstructured":"Pachigolla G, Prasher P, Di Pascuale MA, McCulley JP, McHenry JG, Mootha VV. Evaluation of the role of ProKera in the management of ocular surface and orbital disorders. Eye Contact Lens. 2009, 35:172-5. 10.1097\/ICL.0b013e3181a66a12","journal-title":"Eye Contact Lens"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3181acf816","article-title":"Efficacy and limitation of sutureless amniotic membrane transplantation for acute toxic epidermal necrolysis","volume":"29","author":"Shay E","year":"2010","unstructured":"Shay E, Khadem JJ, Tseng SC. Efficacy and limitation of sutureless amniotic membrane transplantation for acute toxic epidermal necrolysis. Cornea. 2010, 29:359-61. 10.1097\/ICO.0b013e3181acf816","journal-title":"Cornea"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31823d02a8","article-title":"Indications and outcomes of amniotic membrane transplantation in the management of acute stevens-johnson syndrome and toxic epidermal necrolysis:  a case-control study","volume":"31","author":"Hsu M","year":"2012","unstructured":"Hsu M, Jayaram A, Verner R, Lin A, Bouchard C. Indications and outcomes of amniotic membrane transplantation in the management of acute stevens-johnson syndrome and toxic epidermal necrolysis:  a case-control study. Cornea. 2012, 31:1394-402. 10.1097\/ICO.0b013e31823d02a8","journal-title":"Cornea"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.08.040","article-title":"Management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids","volume":"149","author":"Shammas MC","year":"2010","unstructured":"Shammas MC, Lai EC, Sarkar JS, Yang J, Starr CE, Sippel KC. Management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids. Am J Ophthalmol. 2010, 149:203-213.e2. 10.1016\/j.ajo.2009.08.040","journal-title":"Am J Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e318243fee3","article-title":"\"Triple-TEN\" in the treatment of acute ocular complications from toxic epidermal necrolysis","volume":"32","author":"Tomlins PJ","year":"2013","unstructured":"Tomlins PJ, Parulekar MV, Rauz S. \"Triple-TEN\" in the treatment of acute ocular complications from toxic epidermal necrolysis. Cornea. 2013, 32:365-9. 10.1097\/ICO.0b013e318243fee3","journal-title":"Cornea"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2020.05.003","article-title":"The effects of systemic cyclosporine in acute Stevens-Johnson syndrome\/toxic epidermal necrolysis on ocular disease","volume":"19","author":"Hall LN","year":"2021","unstructured":"Hall LN, Shanbhag SS, Rashad R, Chodosh J, Saeed HN. The effects of systemic cyclosporine in acute Stevens-Johnson syndrome\/toxic epidermal necrolysis on ocular disease. Ocul Surf. 2021, 19:128-32. 10.1016\/j.jtos.2020.05.003","journal-title":"Ocul Surf"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167120","article-title":"The effect of intravenous immunoglobulin combined with corticosteroid on the progression of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis","volume":"11","author":"Ye LP","year":"2016","unstructured":"Ye LP, Zhang C, Zhu QX. The effect of intravenous immunoglobulin combined with corticosteroid on the progression of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis. PLoS One. 2016, 11:e0167120. 10.1371\/journal.pone.0167120","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701653","article-title":"High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits","volume":"19","author":"Yip LW","year":"2005","unstructured":"Yip LW, Thong BY, Tan AW, Khin LW, Chng HH, Heng WJ. High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits. Eye (Lond). 2005, 19:846-53. 10.1038\/sj.eye.6701653","journal-title":"Eye (Lond)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2013.27.5.331","article-title":"Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome","volume":"27","author":"Kim KH","year":"2013","unstructured":"Kim KH, Park SW, Kim MK, Wee WR. Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome. Korean J Ophthalmol. 2013, 27:331-40. 10.3341\/kjo.2013.27.5.331","journal-title":"Korean J Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/65698-sutureless-amniotic-membrane-prokera-and-intravenous-immunoglobulin-in-the-management-of-ocular-complications-of-stevens-johnson-syndrome-toxic-epidermal-necrolysis-overlap","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:16Z","timestamp":1707506836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/65698-sutureless-amniotic-membrane-prokera-and-intravenous-immunoglobulin-in-the-management-of-ocular-complications-of-stevens-johnson-syndrome-toxic-epidermal-necrolysis-overlap"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,8]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.16989","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,8]]}}}